Welcome to

Epitope Announces Management Changes

    BEAVERTON, Ore., Jan. 7 /PRNewswire/ -- Epitope, Inc. (Nasdaq: EPTO) today
announced changes in the company's management.
    As previously announced, Charles E. Bergeron, Vice President of
Operations, has become the company's Chief Financial Officer following the
retirement of Gilbert N. Miller in connection with the spin-off of Agritope,
Inc.  Mr. Bergeron joined the company in August 1993 as President and Chief
Executive Officer of its wholly owned subsidiary, Agrimax Floral Products,
Inc.  He was named Vice President of Operations -- Epitope Medical Products in
June 1995.  From 1978 to 1992, Mr. Bergeron was Senior Vice President -
Finance of Freightliner Corporation, a Portland, Oregon truck manufacturer.
Mr. Miller will now devote his full-time efforts to serving as Executive Vice
President, Chief Financial Officer and Director of Agritope.
    J. Richard George, Ph.D., has been named Chief Scientific Officer of the
company.  In his new role, Dr. George will be responsible for the company's
research and product development groups.  Dr. George joined the company in
March 1995.  A career scientist, Dr. George previously served the Centers for
Disease Control and Prevention (CDC), Atlanta, Georgia, which he joined in
1960.  He held a series of management and technical positions at the CDC,
becoming Chief, Developmental Technology, Laboratory Investigations Branch,
Division of HIV/AIDS in 1988.
    John H. Fitchen, M.D., Senior Vice President and Chief Operating Officer,
will leave the company to pursue other interests.  Cathleen M. McKay, Vice
President of Sales and Marketing, will also leave the company after a
transition period.  The company has initiated a nationwide search for her
replacement and for qualified candidates for the newly created position of
Vice President of New Business Development.
    "Now that we have completed the spin-off of our Agritope subsidiary, the
company will shift its efforts from broad-based research and development to
focus on expanding sales of medical diagnostic products in our current core
markets and on pursuing new opportunities," stated John W. Morgan, President
and Chief Executive Officer.  "The management changes announced today are one
component of our plan to drive the company to profitability."
    The company also announced changes to its board of directors.  Mr. Morgan
has been appointed to the board of directors to fill a vacancy created by the
retirement of Adolph J. Ferro, Ph.D. from the board in connection with the
Agritope spin-off.  Dr. Ferro will now devote his full-time efforts to his
positions as Chairman of the Board, President and Chief Executive Officer of
    Richard K. Donahue and R. Douglas Norby have informed the company that
they will retire from the board as of February 17, 1998, the date of the
company's annual meeting of shareholders.  The board's nominating committee
has begun the process of selecting replacements for Mr. Donahue and Mr. Norby.
    Epitope, Inc. is an Oregon corporation that develops and markets medical
diagnostic products.  Its principal products, including the OraSure(R) oral
specimen collection device, focus on the use of oral fluid to detect HIV
infection and other conditions, and are marketed primarily in the life
insurance and public health sectors.

Source: EPITOPE Inc.

Content of this page is copyright and reprinted here for educational and historical information.
Copyright 2004 - 2018 - Ekim Notnud - All rights Reserved
This site is an unofficial historical site and not affiliated with Epitope, Inc.

  Click for Heirloom Tomato Seed Selection Victory Seed Company Save Seeds - Victory Horticultural Library